相关实验视频
Updated: Jan 21, 2026

07:56
Using CRISPR/Cas9 to Knock Out GM-CSF in CAR-T Cells
Published on: July 22, 2019
11.8K
改进CAR T细胞中的CRISPR-Cas9屏幕:用于图书馆准备的精细方法
Maider Garnica1, Patxi San Martin-Uriz2, Paula Rodriguez-Marquez2
1Hemato-Oncology Program, Cima Universidad de Navarra, IdiSNA.
Journal of visualized experiments : JoVE
|January 19, 2026
概括
这项研究优化了对仿真抗原受体 (CAR) T 细胞的集群定期间隔的短时间palindromic重复 (CRISPR) -Cas9查. 改进的协议增强了sgRNA检索,有助于发现基因点,以提高CAR T细胞治疗的疗效.
科学领域:
- 免疫治疗是一种免疫疗法.
- 基因编辑 基因编辑
- 癌症研究 癌症研究
背景情况:
- 化学抗原受体 (CAR) T细胞疗法在血液癌症中表现有前途,但在固体瘤和复发中面临挑战.
- 识别CAR T细胞功能的基因调节者对于改善治疗持续性和克服耐药性至关重要.
- 聚类正规间隔短平行体重复 (CRISPR) -Cas9查是细胞功能的系统基因发现的强大工具.
研究的目的:
- 为了优化一种CRISPR-Cas9淘汰查协议,用于初级人类CAR T细胞.
- 在查图书馆准备过程中提高单向导RNA (sgRNA) 检索的效率.
- 为了能够识别提高CAR T细胞有效性和持久性的遗传决定因素.
主要方法:
- 开发一种优化的CRISPR-Cas9查协议,用于初级人类CAR T细胞.
- 纳入一个中间步骤,包括酶消化和选择性拉下sgRNA磁带,以减少基因组DNA (gDNA) 携带.
- 测试该协议在从CAR T细胞屏幕中检索sgRNA信息的效率.
主要成果:
- 优化的协议显著提高了第一个PCR放大步骤的效率.
- 取得了成功的sgRNA信息检索,这以前是传统PCR方法难以捉摸的.
- 修改后的工作流程在具有挑战性的样本中表现出有效性,比如初级人类CAR T细胞.
结论:
- 优化的CRISPR-Cas9选工作流便于在困难的样本中准备图书馆.
- 这种改进的方法可以识别关键的遗传点,以加强CAR T细胞治疗.
- 这些发现有助于推进对血液和固体瘤的CAR T细胞疗效.
相关概念视频
CRISPR
57.6K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
57.6K
CRISPR/Cas9 Genome Editing
1.8K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
1.8K
CRISPR and crRNAs
18.7K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
18.7K
Improving Translational Accuracy
14.1K
Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
14.1K
Improving Translational Accuracy
3.6K
3.6K
The Antiviral System of Bacteria and Archaea: CRISPR
637
CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats is a adaptive immune system found in bacteria and archaea that protects against viral infections. This system enables prokaryotic cells to identify, remember, and neutralize foreign genetic elements, primarily bacteriophages, by storing fragments of the invader’s DNA as a genetic memory.The CRISPR immune response begins during an initial infection. Cas (CRISPR-associated) proteins play a central role in this...
637

